Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Life (Basel, Switzerland)|January 23, 2024
Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid CancerChristos Cortas, Haris Charalambous
Current Oncology (Toronto, Ont.)|March 27, 2026
Lenvatinib-Induced Acalculous Cholecystitis-An Often-Unrecognized Toxicity: A Case Series and Literature ReviewChristos Cortas, Chloe Symeonidou, Haris Charalambous
BMC Palliative Care|January 1, 2015
Attitudes and referral patterns of lung cancer specialists in Europe to Specialized Palliative Care (SPC) and the practice of Early Palliative Care (EPC)Haris Charalambous, Athanasios Pallis, Baktiar Hasan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 22, 2017
The impact of specialized palliative care on cancer patients' health-related quality of life: a systematic review and meta-analysisAngelos P Kassianos, Myria Ioannou, Marianna Koutsantoni, et al.
Oxford Medical Case Reports|June 17, 2026
Long-term complete radiological response to immunotherapy in a patient with metastatic NSCLC and active rheumatoid arthritisEleanor Roy, Amir Arshia Emam Jomeh, Eleni Xenophontos, et al.
International Journal of Molecular Sciences|June 26, 2026
The Predictive Role of ctDNA and CTCs in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy: A Systematic Review and Meta-AnalysisAndrea C Kakouri, Maria Spiliotaki, Constantinos Deltas, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Docetaxel and Ramucirumab as Subsequent Treatment After First-Line Immunotherapy-Based Treatment for Metastatic Non-Small-Cell Lung Cancer: A Retrospective Study and Literature ReviewSotiris Loizidis, Paris Vogazianos, Zoe Kordatou, et al.
Molecular Oncology|September 30, 2022
Dynamic monitoring of PD-L1 and Ki67 in circulating tumor cells of metastatic non-small cell lung cancer patients treated with pembrolizumabMaria Spiliotaki, Christiana Michael Neophytou, Paris Vogazianos, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2011
Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancerEliza Hawkes, Alicia F C Okines, Demetris Papamichael, et al.
Translational Lung Cancer Research|July 17, 2025
Monitoring pembrolizumab response in patients with metastatic non-small cell lung cancer using circulating tumour DNA and circulating tumour cellsAndrea C Kakouri, Maria Spiliotaki, Eleni M Loizidou, et al.
Pageof 3